Lifeboat Foundation

San Diego based biotech Immunicom has developed an innovative therapeutic device that is intended to remove specific factors from blood that prevent our immune systems from fighting disease. Existing “therapeutic apheresis” treatments usually involve modification to cells harvested from patients or some form of plasma exchange. Immunicom’s technology uses a similar treatment procedure but says its approach of “capturing” targeted molecules is very different from other treatments.

Immunicom creates customised molecules that are designed to capture specific proteins or cytokines, but instead of turning those into drugs, it deploys them via its proprietary cartridges, which are essentially small liquid filters that can be fitted into any plasmapheresis machine. In a treatment similar to dialysis, the cartridges are used to treat a patient’s blood and plasma outside their body, reducing the levels of the target factors, with the goal of enabling the immune system to fight disease.

While Immunicom has focused its initial efforts on treatments for cancer, the company claims its technology can also potentially be applied to longevity and the treatment of a wide range of age-related diseases.

The Information has a simple mission: deliver important, deeply reported stories about the technology business you won’t find elsewhere. Many of the most influential people in the industry turn to us for fresh information and original insight.

In this episode, filmed in early 2021, Sam and Peter discuss the creation of OpenAI and GPT-3, what the future of OpenAI will bring to humanity, and the power of AI/Human collaboration.

Sam Altman is the Co-Founder and CEO of OpenAI and former president of Y Combinator. OpenAI is an artificial intelligence research laboratory that creates programs, such as GPT-3, ChatGPT, and DALL-E 2, for the benefit of humanity.

Continue reading “The Rise of OpenAI With Sam Altman (OpenAI CEO) | Moonshots and Mindsets” »

Get a Wonderful Person Tee: https://teespring.com/stores/whatdamath.
More cool designs are on Amazon: https://amzn.to/3wDGy2i.
Alternatively, PayPal donations can be sent here: http://paypal.me/whatdamath.

Hello and welcome! My name is Anton and in this video, we will talk about new announcement about a potential breakthrough in fusion.
Links:
https://theconversation.com/how-far-has-nuclear-fusion-power…ogy-195114
https://aip.scitation.org/doi/10.1063/5.0085304
https://www.llnl.gov/news/national-ignition-facility-experim…n-ignition.
https://journals.aps.org/prl/abstract/10.1103/PhysRevLett.129.075001

Previous video with details: https://youtu.be/5M5U2_9eEgM
#fusion #physics #breakingnews.

Continue reading “Was There a Major Breakthrough in Fusion? Not Really…Here Are The Facts” »

Enjoy my latest creation of video clips with S/T in Spanish, in this case made with selected excerpts from a video recently published by David Sinclair.

In the description of the video is the link for those who later want to see the full original video.

Continue reading “David Sinclair Talks about the Future of Longevity Research (Clips with S/T in Spanish)” »

The mission of the European Space Agency (ESA) is the peaceful exploration and use of space for the benefit of everyone. We watch over Earth, develop and launch inspiring and unique space projects, train astronauts and push the boundaries of science and technology, seeking answers to the big science questions about the Universe.

We are a community of scientists, engineers and business professionals from all over Europe working together in a diverse and multinational environment.

This page addresses some of the most frequently asked questions about becoming an ESA astronaut. If your question is not answered below, it may be answered in the Astronaut Applicant Handbook or vacancy notices.

While scientists around the world pursue ways to extend the human healthspan, cancer cells have found a way to become immortal.

For the first time, researchers have discovered how one type of cancer – melanoma – achieves that immortality.

The data will help astronomers understand how the universe’s oldest galaxies formed.

Bioengineers used a modular, step-by-step chemical technique to create algae that carry antibiotic payloads.